The growth in the historic period can be attributed to increasing infertility rates, expansion of ivf treatment availability, rising maternal age trends, growing acceptance of fertility treatments, improved hormone extraction and formulation techniques.
The growth in the forecast period can be attributed to increasing adoption of personalized fertility protocols, rising demand for home-based fertility treatment support, expansion of global fertility tourism, growing investments in reproductive health services, increasing focus on treatment success rate optimization. Major trends in the forecast period include increasing use of assisted reproductive technology treatments, rising adoption of hormonal fertility therapies, growing demand for injectable gonadotropin medications, expansion of fertility clinic networks, enhanced focus on optimized ovarian stimulation protocols.
The rising prevalence of infertility is expected to fuel the growth of the Menopur market in the coming years. Infertility is defined as the inability to achieve pregnancy after one year of regular, unprotected intercourse. The increase in infertility is mainly attributed to lifestyle changes, environmental pollutants, and delayed childbearing. Menopur is used in infertility treatment to stimulate the ovaries to produce multiple eggs, thereby enhancing the likelihood of conception. For example, in April 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that around 17.5% of the adult population, or roughly 1 in 6 people globally, experience infertility, underscoring the urgent need to improve access to affordable, high-quality fertility care for affected individuals. Consequently, the growing prevalence of infertility is driving the expansion of the Menopur market.
The rise in maternal age is expected to propel the growth of the Menopur market going forward. Maternal age refers to the age of a woman at the time of pregnancy or childbirth, influencing fertility and pregnancy outcomes. The rise in maternal age is linked to factors such as delayed marriage, focus on career, and advancements in fertility treatments that enable women to have children later in life. Menopur is advantageous for women of advanced maternal age, as it stimulates the ovaries to produce multiple eggs, increasing the likelihood of conception despite age-related fertility declines. For instance, in April 2025, according to the Office for National Statistics (ONS), a UK-based independent producer of official statistics, the average age of women in England and Wales at childbirth (standardized mean age of a mother) was 30.9 years in 2023. Therefore, the rise in maternal age is driving the growth of the Menopur market.
The rise in healthcare spending is expected to propel the growth of the Menopur market in the coming years. Healthcare spending refers to the financial resources dedicated to delivering healthcare services. The increasing healthcare expenditure is driven by factors such as aging populations, the growing prevalence of chronic diseases, advancements in medical technology, and the heightened demand for more specialized and personalized care. Menopur contributes to healthcare spending by offering an effective fertility treatment option, potentially minimizing the need for extended or multiple cycles of assisted reproductive technologies, thereby optimizing treatment costs. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government department for official statistics, total healthcare expenditure in the UK increased by 5.6% in nominal terms from 2022 to 2023, representing a notable acceleration compared to the 0.9% growth recorded in 2022. Consequently, the rise in healthcare spending is driving the growth of the Menopur market.
Major companies operating in the menopur market are Ferring Pharmaceuticals.
North America was the largest region in the menopur market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menopur market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the menopur market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs are impacting the menopur market by increasing costs of imported biological raw materials, hormone extraction inputs, sterile injectable packaging, and cold-chain logistics systems. Fertility clinics and hospital pharmacies in North America and Europe are most affected due to dependence on cross-border biologic sourcing, while Asia-Pacific faces cost pressures on formulation and export activities. These tariffs are contributing to higher treatment costs and access challenges for patients. However, they are also encouraging regional biologics processing, localized packaging operations, and improved supply chain security for fertility medications.
The menopur market research report is one of a series of new reports that provides menopur market statistics, including menopur industry global market size, regional shares, competitors with a menopur market share, detailed menopur market segments, market trends and opportunities, and any further data you may need to thrive in the menopur industry. This menopur market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Menopur is a fertility medication that contains human menopausal gonadotropin (hMG), which consists of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Menopur is mainly used to address certain fertility issues in women, especially those undergoing Assisted Reproductive Technology (ART) procedures such as in vitro fertilization (IVF). It aids in stimulating the growth of multiple ovarian follicles, enhancing the likelihood of successful egg retrieval and fertilization.
The primary indications in the Menopur market are infertility treatment and hypogonadism. Infertility treatment involves medical interventions, therapies, or procedures aimed at helping individuals or couples achieve pregnancy and address challenges related to infertility. Available formulations include injectable solutions and pre-filled syringes. Distribution channels include hospital pharmacies, specialty clinics, retail pharmacies, and online pharmacies, while end users comprise both women and men.
The menopur market consists of sales of menopur injection (hMG), menopur pre-filled syringes and menopur vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The growth in the forecast period can be attributed to increasing adoption of personalized fertility protocols, rising demand for home-based fertility treatment support, expansion of global fertility tourism, growing investments in reproductive health services, increasing focus on treatment success rate optimization. Major trends in the forecast period include increasing use of assisted reproductive technology treatments, rising adoption of hormonal fertility therapies, growing demand for injectable gonadotropin medications, expansion of fertility clinic networks, enhanced focus on optimized ovarian stimulation protocols.
The rising prevalence of infertility is expected to fuel the growth of the Menopur market in the coming years. Infertility is defined as the inability to achieve pregnancy after one year of regular, unprotected intercourse. The increase in infertility is mainly attributed to lifestyle changes, environmental pollutants, and delayed childbearing. Menopur is used in infertility treatment to stimulate the ovaries to produce multiple eggs, thereby enhancing the likelihood of conception. For example, in April 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that around 17.5% of the adult population, or roughly 1 in 6 people globally, experience infertility, underscoring the urgent need to improve access to affordable, high-quality fertility care for affected individuals. Consequently, the growing prevalence of infertility is driving the expansion of the Menopur market.
The rise in maternal age is expected to propel the growth of the Menopur market going forward. Maternal age refers to the age of a woman at the time of pregnancy or childbirth, influencing fertility and pregnancy outcomes. The rise in maternal age is linked to factors such as delayed marriage, focus on career, and advancements in fertility treatments that enable women to have children later in life. Menopur is advantageous for women of advanced maternal age, as it stimulates the ovaries to produce multiple eggs, increasing the likelihood of conception despite age-related fertility declines. For instance, in April 2025, according to the Office for National Statistics (ONS), a UK-based independent producer of official statistics, the average age of women in England and Wales at childbirth (standardized mean age of a mother) was 30.9 years in 2023. Therefore, the rise in maternal age is driving the growth of the Menopur market.
The rise in healthcare spending is expected to propel the growth of the Menopur market in the coming years. Healthcare spending refers to the financial resources dedicated to delivering healthcare services. The increasing healthcare expenditure is driven by factors such as aging populations, the growing prevalence of chronic diseases, advancements in medical technology, and the heightened demand for more specialized and personalized care. Menopur contributes to healthcare spending by offering an effective fertility treatment option, potentially minimizing the need for extended or multiple cycles of assisted reproductive technologies, thereby optimizing treatment costs. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government department for official statistics, total healthcare expenditure in the UK increased by 5.6% in nominal terms from 2022 to 2023, representing a notable acceleration compared to the 0.9% growth recorded in 2022. Consequently, the rise in healthcare spending is driving the growth of the Menopur market.
Major companies operating in the menopur market are Ferring Pharmaceuticals.
North America was the largest region in the menopur market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menopur market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the menopur market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs are impacting the menopur market by increasing costs of imported biological raw materials, hormone extraction inputs, sterile injectable packaging, and cold-chain logistics systems. Fertility clinics and hospital pharmacies in North America and Europe are most affected due to dependence on cross-border biologic sourcing, while Asia-Pacific faces cost pressures on formulation and export activities. These tariffs are contributing to higher treatment costs and access challenges for patients. However, they are also encouraging regional biologics processing, localized packaging operations, and improved supply chain security for fertility medications.
The menopur market research report is one of a series of new reports that provides menopur market statistics, including menopur industry global market size, regional shares, competitors with a menopur market share, detailed menopur market segments, market trends and opportunities, and any further data you may need to thrive in the menopur industry. This menopur market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Menopur is a fertility medication that contains human menopausal gonadotropin (hMG), which consists of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Menopur is mainly used to address certain fertility issues in women, especially those undergoing Assisted Reproductive Technology (ART) procedures such as in vitro fertilization (IVF). It aids in stimulating the growth of multiple ovarian follicles, enhancing the likelihood of successful egg retrieval and fertilization.
The primary indications in the Menopur market are infertility treatment and hypogonadism. Infertility treatment involves medical interventions, therapies, or procedures aimed at helping individuals or couples achieve pregnancy and address challenges related to infertility. Available formulations include injectable solutions and pre-filled syringes. Distribution channels include hospital pharmacies, specialty clinics, retail pharmacies, and online pharmacies, while end users comprise both women and men.
The menopur market consists of sales of menopur injection (hMG), menopur pre-filled syringes and menopur vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Menopur Market Characteristics
3. Menopur Market Supply Chain Analysis
4. Global Menopur Market Trends and Strategies
5. Menopur Market Analysis of End Use Industries
7. Global Menopur Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Menopur Total Addressable Market (TAM) Analysis for the Market
9. Menopur Market Segmentation
10. Menopur Market Regional and Country Analysis
11. Asia-Pacific Menopur Market
12. China Menopur Market
13. India Menopur Market
14. Japan Menopur Market
15. Australia Menopur Market
16. South Korea Menopur Market
17. Western Europe Menopur Market
18. UK Menopur Market
19. Germany Menopur Market
20. France Menopur Market
21. Eastern Europe Menopur Market
22. North America Menopur Market
23. USA Menopur Market
24. Canada Menopur Market
25. South America Menopur Market
26. Middle East Menopur Market
27. Africa Menopur Market
29. Menopur Market Competitive Landscape and Company Profiles
32. Menopur Market High Potential Countries, Segments and Strategies
33. Appendix
Executive Summary
Menopur Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses menopur market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for menopur? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The menopur market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Indication: Infertility Treatment; Hypogonadism2) By Formulation: Injectable Solution; Pre-Filled Syringes
3) By Distribution Channel: Hospital Pharmacies; Specialty Clinics; Retail Pharmacies; Online Pharmacies
4) By End User: Women; Men
Companies Mentioned: Ferring Pharmaceuticals
Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Menopur market report include:- Ferring Pharmaceuticals
